<?xml version="1.0" encoding="UTF-8"?>
<p>12. Page 14, "Meanwhile, in trials with IFNs, the treatment group was not obviously affected (P&lt;0.00001, I2=100%). Are they talking about heterogeneity? The heterogeneity is high with I2=100.</p>
